"Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt of Gujarat along with Hester Biosciences and OmniBRx has also firmed up its discussions with Bharat Biotech to scale up the COVAXIN technology and to produce minimum 20 million doses per month. Technology transfer agreements have been finalised with all manufacturers,” the DBT said in a statement.
In addition to three public sector enterprises (PSEs) that signed pacts with Bharat Biotech to produce Covaxin, three more Ahmedabad-based firms including State-owned Gujarat Biotechnology Research
COVID-19: Gujarat government extends night curfew in 36 cities till May 18
PTI Photo
In a bid to curb the spread of COVID-19 virus, the Gujarat govt has decided to extend night curfew in 36 cities for a week till May 18. Chief Minister Vijay Rupani had ruled of imposing a lockdown in the state and so a curfew was imposed in the state.
Apart from night curfew, the state had also imposed certain other daytime restrictions till May 12 to check the spread of the virus.
Although, showing prepardness, the CM said that a detailed action plan will be chalked out in the coming days to tackle a possible third wave.
Covid strain in Vadodara still a mystery | Vadodara News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
The COVID-19 vaccine is likely to arrive in Delhi by early next week.
New Delhi: The number of fresh COVID-19 cases in India increased by 20,346 since yesterday, indicating a 12% spike, to hit 1,03,95,278. Of these, a little over 2.8 lakh were active cases. The number of deaths in the past 24 hours increased by 222 to touch an overall 1,50,336. Maharashtra, Karnataka, Andhra Pradesh, Tamil Nadu, and Kerala remained the worst-hit, reporting the bulk of the fresh cases as well as deaths. Maharashtra recorded 4,382 new cases and 66 deaths - by far the most among all states.
Here s your 10-point cheatsheet to this big story:
While the US and China race to vaccinate their populations, tens of millions of doses prepared for India are sitting in storage despite having been authorised for use. New Delhi and Serum Institute of India, the world s biggest vaccine maker by volume and AstraZeneca Plc s local partner, have engaged in months of haggling behi